EP0963440A4 - Methodes ameliorees de transduction cellulaire - Google Patents

Methodes ameliorees de transduction cellulaire

Info

Publication number
EP0963440A4
EP0963440A4 EP97950669A EP97950669A EP0963440A4 EP 0963440 A4 EP0963440 A4 EP 0963440A4 EP 97950669 A EP97950669 A EP 97950669A EP 97950669 A EP97950669 A EP 97950669A EP 0963440 A4 EP0963440 A4 EP 0963440A4
Authority
EP
European Patent Office
Prior art keywords
improved cell
cell transduction
transduction methods
methods
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97950669A
Other languages
German (de)
English (en)
Other versions
EP0963440A1 (fr
Inventor
Isaiah J Fidler
Zhongyun Dong
Rakesh Kumar
Original Assignee
Regents Board Of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regents Board Of filed Critical Regents Board Of
Publication of EP0963440A1 publication Critical patent/EP0963440A1/fr
Publication of EP0963440A4 publication Critical patent/EP0963440A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/193Colony stimulating factors [CSF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP97950669A 1996-11-20 1997-11-19 Methodes ameliorees de transduction cellulaire Withdrawn EP0963440A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3133096P 1996-11-20 1996-11-20
US31330P 1996-11-20
PCT/US1997/021475 WO1998022605A1 (fr) 1996-11-20 1997-11-19 Methodes ameliorees de transduction cellulaire

Publications (2)

Publication Number Publication Date
EP0963440A1 EP0963440A1 (fr) 1999-12-15
EP0963440A4 true EP0963440A4 (fr) 2004-12-29

Family

ID=21858846

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97950669A Withdrawn EP0963440A4 (fr) 1996-11-20 1997-11-19 Methodes ameliorees de transduction cellulaire

Country Status (4)

Country Link
EP (1) EP0963440A4 (fr)
JP (1) JP2001505205A (fr)
CA (1) CA2275438A1 (fr)
WO (1) WO1998022605A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004016021A (ja) 2002-06-12 2004-01-22 Japan Science & Technology Corp 抗体および阻害剤並びにそれを用いた形質転換方法および形質転換キット

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4442587A1 (de) * 1994-11-30 1996-08-01 Boehringer Ingelheim Int Verfahren zum Einbringen von Fremdmaterial in höhere eukaryotische Zellen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5656465A (en) * 1994-05-04 1997-08-12 Therion Biologics Corporation Methods of in vivo gene delivery
US5626862A (en) * 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
US5552309A (en) * 1994-09-30 1996-09-03 Indiana University Foundation Use of polyols for improving the introduction of genetic material into cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4442587A1 (de) * 1994-11-30 1996-08-01 Boehringer Ingelheim Int Verfahren zum Einbringen von Fremdmaterial in höhere eukaryotische Zellen

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1988, SHIROKI K ET AL: "ACTIVATION OF THE HUMAN BETA INTERFERON GENE BY THE ADENOVIRUS TYPE 12 E1B GENE", XP002285026, Database accession no. PREV198885057675 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1992, LALLEMAND C ET AL: "AN ANTISENSE INTERFERON-BETA RNA ABOLISHES REPRESSION OF C-FOS GENE EXPRESSION", XP002283638, Database accession no. PREV199294039408 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1992, NIELSCH U ET AL: "INDUCED EXPRESSION OF THE ENDOGENOUS BETA INTERFERON GENE IN ADENOVIRUS TYPE 5-TRANSFORMED RAT FIBROBLASTS", XP002285025, Database accession no. PREV199293135844 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1994, NICKOLAUS PETER ET AL: "Inhibition by interleukin-4 of constitutive beta interferon synthesis in mouse macrophages", XP002283639, Database accession no. PREV199497512589 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1997, DONG ZHONGYUN ET AL: "Neutralization of endogenous interferon-beta increases the efficiency of adenoviral vector-mediated gene transduction", XP002283640, Database accession no. PREV199799707380 *
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, vol. 17, no. 7, 1997, pages 401 - 407, ISSN: 1079-9907 *
JOURNAL OF VIROLOGY, vol. 62, no. 1, 1988, pages 325 - 330, ISSN: 0022-538X *
JOURNAL OF VIROLOGY, vol. 66, no. 4, 1992, pages 1884 - 1890, ISSN: 0022-538X *
JOURNAL OF VIROLOGY, vol. 68, no. 10, 1994, pages 6763 - 6766, ISSN: 0022-538X *
ONCOGENE, vol. 7, no. 6, 1992, pages 1109 - 1118, ISSN: 0950-9232 *
See also references of WO9822605A1 *

Also Published As

Publication number Publication date
WO1998022605A1 (fr) 1998-05-28
EP0963440A1 (fr) 1999-12-15
JP2001505205A (ja) 2001-04-17
CA2275438A1 (fr) 1998-05-28

Similar Documents

Publication Publication Date Title
DE69603416D1 (de) Elektrochemischer Immunobiosensor
DE69739030D1 (de) Elektrochemischer sensor
DE69729672D1 (de) Biosensor
DE69727485D1 (de) Elektrochemischer sensor
DE69718481D1 (de) Elektrolyt
DE69839250D1 (de) Verbesserte elektrochemische biosensor-teststreifen
DE59611425D1 (de) Messfühler
BR9707531A (pt) ancora de enxerto
GB2318874B (en) Electrochemical multi-gas sensor
DE69708751D1 (de) Messfühler
DK0944519T3 (da) Drejetårn-lejekonstruktion til skibe
DE69839754D1 (de) Kurzzellenmultiplexer
DE59711247D1 (de) Elektrochemischer Sensor
DE69737627D1 (de) Analysezelle
BR9607041A (pt) Célula eletroquímica primário
DE59510521D1 (de) Elektrochemischer messfühler
DE69620552D1 (de) Elektrochemischer Sensor
DE69835316D1 (de) Festelektrolyt
DE69633441D1 (de) Elektrochemischer sensor
DE59711056D1 (de) Festelektrolyt-gassensor
DE59701451D1 (de) Mikromechanische transmissionsmesszelle
ID24760A (id) Turunan-turunan piridilpirol
DE69834626D1 (de) Elektrochemisches Bauelement
TR199600902A2 (tr) Hücre transfeksiyonu.
DE19780686T1 (de) Schwimmhilfe

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990621

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20041111

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060314